Actively Recruiting

All Genders
ID05701579

Assessment of Anterior Cruciate Ligament (ACL) Degeneratio Mucosa Treatment

Led by Artromedical Konrad Malinowski Clinic · Updated on 2023-01-27

10

Participants Needed

1

Research Sites

52 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Anterior Cruciate Ligament (ACL) Degeneratio Mucosa is a condition caused by mucoid degeneration of the ACL, leading to impaired daily function. The exact cause of this condition is unknown. Researchers are studying a surgical technique called ACL "decompression," which involves making longitudinal incisions and removing extrafibrous mucoid tissue to address this problem. The study focuses on patients with ACL Degeneratio Mucosa who have decided to undergo surgical treatment. This treatment involves the decompression procedure applied to the affected ligament. The study does not mention comparison groups or placebos, as it is observational in nature. Participants will be followed for up to 24 months, during which their knee function will be closely monitored. Assessments include measuring range of motion, knee stability in different directions, and functional scores using the International Knee Documentation Committee Questionnaire (IKDC) and the Knee Injury and Osteoarthritis Outcome Score (KOOS). These evaluations occur at 12 and 24 months after treatment to track recovery and knee performance.

CONDITIONS

Brief Title

Assessment of Anterior Cruciate Ligament (ACL) Degeneratio Mucosa Treatment

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with ACL degeneratio mucosa decided to undergo a surgical treatment
  • Range of motion impairment caused by mucoid or cystic changes in ACL confirmed by MRI
Not Eligible

You will not qualify if you...

  • Non-adherence to the study protocol
  • Active knee inflammation
  • Range of motion impairment due to other extra- and intra-articular reasons

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Surgery and Immediate Post-operative Care

Duration - 1 day

Participants undergo the ACL "decompression" surgical procedure involving longitudinal incisions and evacuation of extrafibrous mucoid tissue, followed by immediate post-operative care.

1 surgical visit (in-person)

Post-operative Follow-up

Duration - 24 months

Participants are monitored for recovery and knee function through scheduled assessments after surgery.

Visits at 12 months and 24 months post-surgery to assess range of motion, knee stability, and functional outcomes

Trial Site Locations

Total: 1 location

1

Artromedical Orthopaedic Clinic

Bełchatów, Łódź Voivodeship, Poland, 97-400

Actively Recruiting

Loading map...

Research Team

K

Konrad Malinowski, MD PhD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Similar Trials

Antero-lateral Ligament Reconstruction Versus Modified Lemai...

Anterior Cruciate Ligament Injuries

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Anterior cruciate ligament abnormalities are associated with accelerated progression of knee joint degeneration in knees with and without structural knee joint abnormalities: 96-month data from the Osteoarthritis Initiative.

A S Gersing, B J Schwaiger, M C Nevitt...

https://pubmed.ncbi.nlm.nih.gov/33775919

Clinical Outcomes of Arthroscopic Notchplasty and Partial Resection for Mucoid Degeneration of the Anterior Cruciate Ligament.

Joong Won Lee, Jung Tae Ahn, Hyun Gon Gwak...

https://pubmed.ncbi.nlm.nih.gov/33467062